Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.
Ismael N, Gemusse H, Mahumane I, Laurindo O, Magul C, Baxter C, Wilkinson E, Hofstra LM, Wagar N, Bila D, Mabunda N, da Silva J, Oliveira T, Raizes E, Preiser W, Manuel P, Ramos A, Vúbil A. Ismael N, et al. Among authors: raizes e. BMC Infect Dis. 2024 Jul 29;24(1):748. doi: 10.1186/s12879-024-09579-4. BMC Infect Dis. 2024. PMID: 39075381 Free PMC article.
Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.
Hunt GM, Kainne Dokubo E, Takuva S, de Oliveira T, Ledwaba J, Dube N, Moodley P, Sabatier J, Deyde V, Morris L, Raizes E. Hunt GM, et al. Among authors: raizes e. J Antimicrob Chemother. 2017 Nov 1;72(11):3222. doi: 10.1093/jac/dkx340. J Antimicrob Chemother. 2017. PMID: 28961961 No abstract available.
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.
Gregson J, Kaleebu P, Marconi VC, van Vuuren C, Ndembi N, Hamers RL, Kanki P, Hoffmann CJ, Lockman S, Pillay D, de Oliveira T, Clumeck N, Hunt G, Kerschberger B, Shafer RW, Yang C, Raizes E, Kantor R, Gupta RK. Gregson J, et al. Among authors: raizes e. Lancet Infect Dis. 2017 Mar;17(3):296-304. doi: 10.1016/S1473-3099(16)30469-8. Epub 2016 Dec 1. Lancet Infect Dis. 2017. PMID: 27914856 Free PMC article.
High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy.
Dziuban EJ, DeVos J, Ngeno B, Ngugi E, Zhang G, Sabatier J, Wagar N, Diallo K, Nganga L, Katana A, Yang C, Rivadeneira ED, Mukui I, Odhiambo F, Redfield R, Raizes E. Dziuban EJ, et al. Among authors: raizes e. Pediatr Infect Dis J. 2017 Aug;36(8):758-760. doi: 10.1097/INF.0000000000001597. Pediatr Infect Dis J. 2017. PMID: 28383390 Free PMC article.
Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.
Godfrey C, Thigpen MC, Crawford KW, Jean-Phillippe P, Pillay D, Persaud D, Kuritzkes DR, Wainberg M, Raizes E, Fitzgibbon J. Godfrey C, et al. Among authors: raizes e. J Infect Dis. 2017 Dec 1;216(suppl_9):S798-S800. doi: 10.1093/infdis/jix137. J Infect Dis. 2017. PMID: 28973412 Free PMC article. Review. No abstract available.
53 results